Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study
Jose M de la Torre Hernandez Cristóbal Urbano-Carrillo Juan F Oteo Dominguez Victor A Jimenez Diaz Antonio E. Gomez Menchero Eladio Galindo Fernández Juan G. Córdoba Soriano Raymundo Ocaranza Eduardo Arroyo Úcar Koldobika Garcia San Roman Silvio Leal Ramon Lopez Palop Ginés Martínez Cáceres Jose A Linares Vicente Georgina Fuertes Ferre Xavier Carrillo Juan C. Rama Merchán Catia Costa Juan Sanchis Renato Fernandes Alberto Rodrigues Jose M Vegas Valle Jesus M Jimenez Mazuecos Hélder Pereira Armando Perez de Prado Pilar Carrillo Sáez Alejandro Gutierez-Barrios Eduardo Pinar Belen Cid Luis Fernandez Tamara Garcia Camarero
Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study
Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study
摘要
引用本文复制引用
Jose M de la Torre Hernandez,Cristóbal Urbano-Carrillo,Juan F Oteo Dominguez,Victor A Jimenez Diaz,Antonio E. Gomez Menchero,Eladio Galindo Fernández,Juan G. Córdoba Soriano,Raymundo Ocaranza,Eduardo Arroyo Úcar,Koldobika Garcia San Roman,Silvio Leal,Ramon Lopez Palop,Ginés Martínez Cáceres,Jose A Linares Vicente,Georgina Fuertes Ferre,Xavier Carrillo,Juan C. Rama Merchán,Catia Costa,Juan Sanchis,Renato Fernandes,Alberto Rodrigues,Jose M Vegas Valle,Jesus M Jimenez Mazuecos,Hélder Pereira,Armando Perez de Prado,Pilar Carrillo Sáez,Alejandro Gutierez-Barrios,Eduardo Pinar,Belen Cid,Luis Fernandez,Tamara Garcia Camarero..Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study[J].老年心脏病学杂志(英文版),2022,19(5):354-366,13.基金项目
The study was funded by an unrestricted grant from Abbott Laboratories(COR10620).Study design,selection of participating centers,collection,management and interpretation of data and manu-script preparation was an exclusive responsibility of the investigators in EPIC foundation and associ-ation,with no involvement/interference of the fun-ding company. (COR10620)